Our Recommendations
Filter
95
Featured
Recommendations
7
New Publications
11
Language
Document type
No document type
72
Studies & Reports
8
Guidelines
4
Fact sheets
4
Resource Platforms
3
Manuals
2
Strategic & Response Plan
2
Countries / Regions
Western and Central Europe
7
Global
4
North Macedonia
2
Eastern Europe
2
Russia
2
India
2
Tajikistan
1
Nepal
1
Colombia
1
Thailand
1
Kenya
1
Mexico
1
Serbia
1
Ghana
1
Albania
1
Senegal
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Morocco
1
Mozambique
1
Africa
1
Latin America and the Carribbean
1
Hungary
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Jamaica
1
Norway
1
Portugal
1
Argentina
1
Lebanon
1
South Africa
1
Uganda
1
Brazil
1
Georgia
1
Indonesia
1
Authors & Publishers
Publication Years
Category
COVID-19
1
x MEDBOX Issue Brief & Annual Reports x
1
Policies
1
Guidelines
1
Studies & Reports
1
Statistics
1
Toolboxes
Substance Use Disorders, Others
95
Substance Use Disorders & Addiction
68
Drugs
9
IEC Substance Use Disorders
6
Alcohol
5
Diverse Chemical Substances
5
General Studies & Reports
4
Cannabis
4
Tobacco
4
Training Manuals
3
Opoids
3
Eastern Europe
3
Mental Health Online Resources
3
Coping with Stress
3
Mental Disorders
3
Mental Health GAP Action Programme
3
Best Practice Models
2
Cocaine
2
Policies & Programmes
2
Training Supporting Material mhGAP
2
General
2
Depression
2
Training & Capacity Building
2
Africa
1
Psychosocial Support (MHPSS)
1
Human Rights
1
Stress
1
Manuals
1
Mental Health & Psychosocial Support
1
Country specific documents
1
MHPSS – Psychosocial Support
1
Children & Mental Health
1
Health Worker
1
Global Overview
1
Community Worker
1
IEC Material Children
1
Modules
1
Self-harm & Suicide
1
Assessment Tools
1
HIV service delivery
1
Community-based Mental Health Care
1
MHPSS Guidelines
1
Report by the Director-General. 75th World health assembly 25 April 2022
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i...
Interactive website: Data by topic; country profiles, microdata
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply...
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use has changed over time, and we are presenting the estimates of their impact on health. Collectively, smoking, alcohol and illicit drug use kills 11.8...
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support the development and improvement of substance abuse treatment services, based on evidence from the litera...
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit metho...
2nd revised edition. Accessed Apri. 17, 2019
Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ...
Best Practice Portal
recommended
The Best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration. It will help you identify tried and tested interventions quickly, allocate resources to what's e...
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
Mental Health & COVID-19
recommended
MEDBOX Issue Brief. No.5
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...
a systematic analysis for the Global Burden of Disease Study 2016.
The Lancet Published:November 01, 2018DOI:https://doi.org/10.1016/S2215-0366(18)30337-7
